Sanofi

Sanofi-aventis responds to the emergency request for humanitarian aid to Lebanon

STUDY FINDINGS PRESENTED ON TAXOTERE REGIMENS

ADJUVANTED FORMULATION OF SANOFI PASTEUR H5N1 PANDEMIC INFLUENZA VACCINE CANDIDATE DEMONSTRATES SIGNIFICANT IMMUNE RESPONSE

PLAVIX® (clopidogrel) LAUNCHED IN JAPAN

Sanofi-aventis: Results First quarter of 2006

TAXOTERE® RECEIVES POSITIVE OPINION

TAXOTERE® RECEIVES U.S. FDA APPROVAL FOR USE IN ADVANCED STOMACH CANCER

Agreement between sanofi-aventis and Roche

STUDY ANALYZES GENE THERAPY FOR PATIENTS AT HIGH RISK FOR AMPUTATION

CHARISMA: NEW STUDY FURTHERS UNDERSTANDING OF THE ROLE OF DUAL ANTIPLATELET THERAPY IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS

Apidra ® A New Rapid-Acting Insulin Analog is Now Available in the United States for Hyperglycemia in Adults with Type 2 and Type 1 Diabetes

RESCHEDULING OF THE TRIAL DATE IN THE UNITED STATES PLAVIX® LITIGATION

Mediearkiv